Position in ABBV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$8,380,618
+$1,315,673 QoQ
Shares Held
33,304
+2.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#1,014
of 4,153 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BRIGHTON JONES LLC holds $86,570,928 across 13 Drug Manufacturers - General names. ABBV ranks #5 (9.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
17,958 | $21,539,365 | |
| 2 | JNJ |
Johnson & Johnson
|
57,725 | $14,660,418 | |
| 3 | AMGN |
Amgen Inc
|
34,281 | $12,413,835 | |
| 4 | MRK |
Merck & Co., Inc.
|
90,183 | $11,588,515 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
33,304 | $8,380,618 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
122,001 | $7,029,697 | |
| 7 | PFE |
Pfizer Inc
|
155,516 | $3,744,825 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
18,796 | $2,374,686 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,380,618 | 33,304 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $7,064,945 | 32,484 | Shares | Sole | 2026-08-07 | |
| 2025-09-30 | $6,612,087 | 28,557 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $5,201,072 | 28,020 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $5,730,372 | 27,350 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $4,071,462 | 22,912 | Shares | Sole | 2025-03-04 | |
| 2024-09-30 | $3,853,032 | 19,511 | Shares | Sole | 2025-03-04 | |
| 2024-06-30 | $3,382,545 | 19,721 | Shares | Sole | 2025-03-04 | |
| 2024-03-31 | $3,504,332 | 19,244 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,612,329 | 16,857 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $2,702,010 | 18,127 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $2,150,156 | 15,959 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $2,474,856 | 15,529 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $2,429,159 | 15,031 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $1,994,897 | 14,864 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,175,484 | 14,204 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $2,307,311 | 14,233 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,841,981 | 13,604 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $1,168,771 | 10,835 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $1,043,046 | 9,260 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,177,866 | 10,884 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $987,815 | 9,219 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $820,805 | 9,371 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $908,655 | 9,255 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $682,205 | 8,954 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||